Pharma Careers for Doctors at Roche – Medic Foo...
Roche Holdings: Hold If You Have It, But Do Not...
en
Roche Pharmaceuticals (division of Roche Group)...
Roche - Pharmaceutical Business review
Roche | Roche Pharma
Roche, Blueprint lung cancer drug wins FDA appr...
Roche begins new clinical trials of multiple sc...
A history of Roche
FDA Approves Roche Immunotherapy for Bladder Ca...
After Failed Tests: Roche Pulls the Plug on Bre...
Roche Announces $250M Deal to Acquire Good Ther...
Roche | Our pharmaceuticals
Roche Says Drug Meets Bladder Cancer Target - WSJ
Pharmaceutical Technology
Roche and Exelixis detail rare success for Cabo...
EMA CHMP recommends approval for Roche’s therap...
Roche scraps Alzheimer’s drug trials after fail...
Roche | Pharma Partnering Contact page
Roche enters obesity drug market with Carmot deal
Roche | Pharma
Roche Revenue Lifted by Cancer and Immunology D...
Roche buys U.S. rights to Roivant bowel disease...
Roche Romania implements new distribution model...
Qui sommes-nous ? | Roche
Roche Sales Rise on Cancer Drugs - WSJ
Switzerland's Roche reports promising results f...
Roche Pharmaceuticals – Element Data
Roche - Pharma Journal
Roche Pharmaceutical Company Name On Labels Sto...
Roche’s MS Drug Reports Promising Results - WSJ
Roche Fights Roche for $9 Billion Drug Business...
New Cancer Immunotherapy Fails in First Roche T...
Roche Pharma enters ophthalmology segment
Obesity drug from Roche shows promise in early ...